We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Immutep Limited | NASDAQ:PBMD | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 1.71 | 1.03 | 1.80 | 0 | 01:00:00 |
From May 2019 to May 2024
The Company is pleased to advise that the name Immutep Limited has been formally adopted after ASIC registration.
The ASX has been informed and the Company will trade under the new ticker IMM from 1 December 2017.
The Company will also trade under the NASDAQ ticker of IMMP.
For further information please contact:
U.S. Investors:Jay Campbell, Vice President of Business Development and Investor Relations, Prima BioMed+1 (917) 860-9404; jay.campbell@primabiomed.com.au
Matthew Beck, The Trout Group LLC+1 (646) 378-2933; mbeck@troutgroup.com
Australian Investors/Media:Matthew Gregorowski, Citadel-MAGNUS+61 2 8234 0105; mgregorowski@citadelmagnus.com
1 Year Immutep Limited Chart |
1 Month Immutep Limited Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
